Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Date:

Share post:




Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing an earlier decision not to approve the drug.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

Blue states will have green light to raise taxes if SALT cap is lifted, former GOP tax chief says

The architect of Donald Trump’s 2017 tax law pushed back Wednesday on calls to lift the cap...

Trump’s Treasury nominee Scott Bessent faces his Senate confirmation hearing. Here are 5 things to watch.

Scott Bessent, President-elect Donald Trump’s nominee for Treasury secretary, will step into the spotlight this week, with...

Yellen says U.S. could’ve kept inflation stable — if it threw up to 15 million people out of work

Treasury Sec. Janet Yellen defended the Biden administration’s economic performance in her last official policy speech, arguing...

JPMorgan, Citi, Wells Fargo and Goldman’s earnings results may boost banks stocks further

The largest banks in the U.S. may justify further gains in stock prices if their earnings updates...

Stock-market investors are getting nervous about this bond-market move that’s only happened twice in over 40 years

Stock-market investors are turning jittery over something which has apparently happened only two times in the bond...

Here’s how Trump could impose tariffs on Denmark in a bid to control Greenland

President-elect Donald Trump Tuesday threatened to place new tariffs on imports from Denmark unless the country gives...

Why eggs are nearly $9 a dozen in California — and when prices could drop

Egg prices at the grocery store shocked many consumers over the recent holiday season, and those prices...

Oil prices struggle for direction as U.S. crude supplies fall and product stocks rise

Oil futures struggled for direction on Wednesday after the U.S. Energy Information Administration reported that commercial crude...